Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 2030116

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 2030116

Lactoferrin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Function, By Application, By Region & Competition, 2021-2031F

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global lactoferrin market is expected to expand from USD 148.39 million in 2025 to USD 249.14 million by 2031, representing a compound annual growth rate of 9.02%. This 80 kDa iron-binding glycoprotein, found naturally in mammalian milk and other bodily secretions, is highly valued for its extensive biological functions, which include immunomodulatory, anti-inflammatory, antiviral, and antimicrobial effects. Market growth is heavily fueled by rising consumer knowledge of its health advantages, especially concerning improved iron uptake and immune system support. Additionally, the increasing use of lactoferrin in pharmaceuticals, dietary supplements, functional foods, and infant formula-where it replicates elements of human breast milk-greatly contributes to the industry's upward trajectory.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 148.39 Million
Market Size 2031USD 249.14 Million
CAGR 2026-20319.02%
Fastest Growing SegmentInfant Formula
Largest MarketAsia Pacific

Even with these positive growth factors, the worldwide lactoferrin industry encounters a significant hurdle due to the steep expenses involved in extracting and purifying the compound from natural sources. These complex procedures demand highly specialized equipment and technology, which ultimately restricts both the scalability and affordability of the end products. Highlighting the raw material requirements of this manufacturing process, the USDA Foreign Agricultural Service noted that fluid milk production in New Zealand reached an estimated 21.7 million metric tons for the 2025 market year, with a substantial share allocated to creating value-added dairy components like lactoferrin.

Market Driver

Growing consumer knowledge regarding the health advantages of lactoferrin is significantly shaping the industry by driving the need for nutritionally enriched and immune-boosting goods. A strong emphasis on ingredient excellence and preventive health measures has led manufacturers to develop items that utilize the established benefits of this glycoprotein. Highlighting this trend, a January 2025 report from FrieslandCampina Ingredients revealed that more than 59% of parents with infants under twelve months old wanted to enhance their child's immune system, prompting the addition of these helpful ingredients into dietary products. This strong buyer enthusiasm is pushing lactoferrin beyond conventional supplements and into the realm of functional beverages and foods, diversifying its practical uses.

Another major catalyst for market growth is the escalating need for lactoferrin in baby formula, driven by its capacity to enhance iron absorption, bolster infant immunity, and replicate components found in breast milk. This surge has led to substantial financial backing for manufacturing and innovation within the sector. As reported by Mejerimedier in September 2024, Arla Foods is enlarging its HOCO facility in Holstebro, Denmark, where construction starting in 2025 will yield a new plant capable of boosting powder output by roughly 180 kg daily to specifically increase lactoferrin eluate production. Emphasizing wider market optimism regarding early life nutrition demands, cellular agriculture investment firm Agronomics injected an additional AUD 3 million into Australian biotechnology company All G in January 2026 as part of a larger AUD 10 million funding initiative aimed at scaling up precision fermentation-based lactoferrin production.

Market Challenge

Elevated manufacturing expenses present a formidable obstacle to the expansion of the worldwide lactoferrin industry. Extracting and refining this ingredient from its primary natural source, mammalian milk, involves complex procedures that demand significant financial backing and highly specialized technological equipment. Consequently, the high costs are passed down to lactoferrin-infused items, reducing their affordability and restricting their reach among wider audiences, especially within demographics highly sensitive to pricing. Additionally, because the extraction techniques are so specialized, scaling up operations is constrained by the need for advanced facilities and massive capital investments.

The International Dairy Federation noted in its 2025 World Dairy Situation Report that the worldwide output of raw, unprocessed milk across all species increased by 2.2% during 2024. Even though this points to an expanding supply of foundational raw materials, the fundamental difficulties and steep expenses associated with extracting a highly pure component like lactoferrin from such vast quantities remain a major hurdle. These enduring operational complexities make it difficult to achieve cost-effective mass production, ultimately slowing down the broader growth potential of the market.

Market Trends

A prominent trend in the industry is the incorporation of lactoferrin into personal care items and cosmeceuticals, a shift motivated by a deepening scientific grasp of its varied biological functions. The ingredient is becoming increasingly attractive for oral care, haircare, and skincare formulations as ongoing studies reveal its potent antioxidant, anti-inflammatory, and antimicrobial traits. Producers are capitalizing on its natural derivation and versatile advantages to formulate solutions for diverse dermatological issues, spanning from anti-aging treatments to acne management. This transition into beauty and wellness sectors is supported by extensive research; as noted on the Morinaga Milk Industry website in December 2025, more than 9,000 global scientific publications now document lactoferrin's broad capabilities and uses outside of standard nutritional applications.

At the same time, the industry is being transformed by a surging consumer appetite for animal-free lactoferrin, driven by a desire for hypoallergenic, ethically sourced, and sustainable components. The use of precision fermentation technology plays a crucial role in creating lactoferrin without relying on animal origins, providing a reliable and scalable substitute for conventional bovine extraction. This movement is drawing significant financial investment and unlocking novel market avenues as businesses strive to align with modern shoppers' ethical and dietary preferences. Illustrating this commercial momentum, a January 2025 FoodNavigator-USA report noted that Strive Nutrition planned to introduce a ready-to-mix protein powder and a functional beverage featuring TurtleTree's animal-free lactoferrin in the first quarter of 2025, highlighting the strong market readiness for these cutting-edge alternatives.

Key Market Players

  • Hilmar Cheese Co Inc
  • Pharming Group NV
  • Royal FrieslandCampina N.V.
  • Synlait Milk Ltd
  • Ingredia SA
  • MP Biomedicals LLC
  • Tatura Milk Industries Ltd
  • Glanbia PLC
  • APS BioGroup Inc
  • ProHealth Care Inc

Report Scope

In this report, the Global Lactoferrin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactoferrin Market, By Function

  • Iron Absorption
  • Anti-inflammatory
  • Intestinal Flora Protection
  • Antibacterial
  • Immune Cell Stimulation
  • Antioxidant

Lactoferrin Market, By Application

  • Food & Beverages
  • Infant Formula
  • Sports & Functional Foods
  • Pharmaceuticals
  • Personal Care Products
  • Animal Feed

Lactoferrin Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactoferrin Market.

Available Customizations:

Global Lactoferrin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 16039

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lactoferrin Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Function (Iron Absorption, Anti-inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, Antioxidant)
    • 5.2.2. By Application (Food & Beverages, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Personal Care Products, Animal Feed)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Lactoferrin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Function
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lactoferrin Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Function
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Lactoferrin Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Function
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Lactoferrin Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Function
        • 6.3.3.2.2. By Application

7. Europe Lactoferrin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Function
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lactoferrin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Function
        • 7.3.1.2.2. By Application
    • 7.3.2. France Lactoferrin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Function
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Lactoferrin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Function
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Lactoferrin Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Function
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Lactoferrin Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Function
        • 7.3.5.2.2. By Application

8. Asia Pacific Lactoferrin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Function
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Lactoferrin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Function
        • 8.3.1.2.2. By Application
    • 8.3.2. India Lactoferrin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Function
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Lactoferrin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Function
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Lactoferrin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Function
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Lactoferrin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Function
        • 8.3.5.2.2. By Application

9. Middle East & Africa Lactoferrin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Function
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Lactoferrin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Function
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Lactoferrin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Function
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Lactoferrin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Function
        • 9.3.3.2.2. By Application

10. South America Lactoferrin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Function
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Lactoferrin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Function
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Lactoferrin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Function
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Lactoferrin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Function
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Lactoferrin Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Hilmar Cheese Co Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Pharming Group NV
  • 15.3. Royal FrieslandCampina N.V.
  • 15.4. Synlait Milk Ltd
  • 15.5. Ingredia SA
  • 15.6. MP Biomedicals LLC
  • 15.7. Tatura Milk Industries Ltd
  • 15.8. Glanbia PLC
  • 15.9. APS BioGroup Inc
  • 15.10. ProHealth Care Inc

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!